Cargando…
Small-molecule inhibitors of carboxylesterase Notum
Notum has recently been identified as a negative regulator of Wnt signaling through the removal of an essential palmitoleate group from Wnt proteins. There are emerging reports that Notum plays a role in human disease, with published data suggesting that targeting Notum could represent a new therape...
Autores principales: | Zhao, Yuguang, Jolly, Sarah, Benvegnu, Stefano, Jones, E Yvonne, Fish, Paul V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Newlands Press Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130783/ https://www.ncbi.nlm.nih.gov/pubmed/33882714 http://dx.doi.org/10.4155/fmc-2021-0036 |
Ejemplares similares
-
Designed switch from covalent to non-covalent inhibitors of carboxylesterase Notum activity
por: Atkinson, Benjamin N., et al.
Publicado: (2023) -
Carboxylesterase
Notum Is a Druggable Target to Modulate
Wnt Signaling
por: Bayle, Elliott D., et al.
Publicado: (2021) -
Structural Insights
into Notum Covalent Inhibition
por: Zhao, Yuguang, et al.
Publicado: (2021) -
Structural characterization of melatonin as an inhibitor of the Wnt deacylase Notum
por: Zhao, Yuguang, et al.
Publicado: (2020) -
Design of a Potent,
Selective, and Brain-Penetrant
Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic
Fragment Hit
por: Willis, Nicky J., et al.
Publicado: (2022)